Searchable abstracts of presentations at key conferences on calcified tissues
Previous issue | Volume 3 | ECTS2014 | Next issue

European Calcified Tissue Society Congress 2014

Prague, Czech Republic
17 May 2014 - 20 May 2014

Card image cap
European Calcified Tissue Society Annual Congress, 17 - 20 May 2014; Prague, Czech Republic

ba0003d1.1 | (1) | ECTS2014

Debate: there are more benefits than risks associated with HRT in postmenopausal women: for the motion

Stevenson John

Hormone replacement therapy (HRT) comprises estrogen, with or without progestogen addition, given to postmenopausal women. HRT is by far the most effective treatment for the relief of menopausal symptoms such as vasomotor and genito-urinary symptoms. It is as effective as alternative treatments for the prevention of postmenopausal osteoporosis. It increases bone mass, reduces bone turnover, and reduces fracture risk at all the important skeletal sites. It has a beneficial effe...

ba0003d1.2 | (1) | ECTS2014

Debate: there are more benefits than risks associated with HRT in postmenopausal women: against the motion

Cauley Jane

Currently menopausal hormone treatment (HT) is not recommended for the prevention of chronic disease. This recommendation is based on reputable science relying largely on the Women’s Health Initiative (WHI), a large methodologically sound, long-term, randomized clinical trial (RCT) of 27 347 women age 50–79 years. A RCT is considered level two evidence in the hierarchy of evidence only below a systematic review of several RCTs. The WHI HT trials were designed to dete...